Cargando…
Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease
Stem cell transplantation and genetic therapies offer potential cures for patients with sickle cell disease (SCD), but these options require advanced medical facilities and are expensive. Consequently, these treatments will not be available for many years to the majority of patients suffering from t...
Autores principales: | Metaferia, Belhu, Cellmer, Troy, Dunkelberger, Emily B., Li, Quan, Henry, Eric R., Hofrichter, James, Staton, Dwayne, Hsieh, Matthew M., Conrey, Anna K., Tisdale, John F., Chatterjee, Arnab K., Thein, Swee Lay, Eaton, William A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546543/ https://www.ncbi.nlm.nih.gov/pubmed/36161945 http://dx.doi.org/10.1073/pnas.2210779119 |
Ejemplares similares
-
Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease
por: Henry, Eric R., et al.
Publicado: (2020) -
The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
por: Janes, Jeff, et al.
Publicado: (2018) -
High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi
por: Bernatchez, Jean A., et al.
Publicado: (2020) -
MWC allosteric model explains unusual hemoglobin-oxygen binding curves from sickle cell drug binding
por: Henry, Eric R., et al.
Publicado: (2021) -
Reframing cancer: challenging the discourse on cancer and cancer drugs—a Norwegian perspective: Reframing Cancer
por: Stenmarck, Mille Sofie, et al.
Publicado: (2021)